(Q30587234)

25 June 2017

1 reference

title

Proton magnetic resonance spectroscopy of the human brain in schizophrenia (English)

1 reference

25 June 2017

0 references

Deicken RF

1

1 reference

25 June 2017

Johnson C

series ordinal

2

1 reference

25 June 2017

Pegues M

series ordinal

3

1 reference

25 June 2017

publication date

1 January 2000

1 reference

Reviews in the Neurosciences

25 June 2017

published in

1 reference

25 June 2017

volume

11

1 reference

25 June 2017

issue

2-3

1 reference

25 June 2017

page(s)

147-158

1 reference

Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

Candidate genes in psychiatry: an epidemiological perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

N-acetylaspartate in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2000.11.2-3.147

10.1515/REVNEURO.2000.11.2-3.147

21 January 2018

Identifiers

DOI

1 reference

25 June 2017

1 reference